Pawanjit Sarna, MD
Pulmonary Disease · South Boston, VANPI 1457379422
Payments from drug & device makers
Across 486 payments — averaging $39.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$10K
- GSK$2K
- AstraZeneca$2K
- Mallinckrodt Hospital Products Inc.$630
- Boehringer Ingelheim$622
- Regeneron Healthcare Solutions, Inc.$487
- plus $4K from 34 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 12 | $10,165 |
| GSK | 140 | $1,821 |
| AstraZeneca | 61 | $1,679 |
| Mallinckrodt Hospital Products Inc. | 27 | $630 |
| Boehringer Ingelheim | 34 | $622 |
| Regeneron Healthcare Solutions, Inc. | 27 | $487 |
| Insmed, Inc. | 22 | $405 |
| Mylan Specialty L.p. | 21 | $312 |
| Sanofi | 17 | $294 |
| Grifols USA, LLC | 14 | $290 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $274 |
| Philips North America LLC | 10 | $170 |
| Amgen | 8 | $165 |
| Bayer | 4 | $160 |
| ANI Pharmaceuticals, Inc. | 5 | $148 |
| Genentech USA, Inc. | 11 | $125 |
| Actelion Pharmaceuticals US, Inc. | 7 | $122 |
| Verona Pharma, Inc. | 5 | $110 |
| Sanofi-aventis U.S. LLC | 1 | $97 |
| Vifor Pharma, Inc. | 4 | $88 |
| Viatris Specialty LLC | 4 | $79 |
| Baxter Healthcare | 3 | $76 |
| Paratek Pharmaceuticals, Inc. | 4 | $68 |
| Merck | 4 | $67 |
| Pharming Healthcare, Inc. | 4 | $66 |
| Novartis | 4 | $57 |
| United Therapeutics Corporation | 3 | $49 |
| Pulmonx Corporation | 2 | $47 |
| Inogen, Inc. | 2 | $39 |
| Electromed, Inc. | 3 | $36 |
| Atricure, Inc. | 1 | $34 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Circassia Inc. | 2 | $24 |
| Phadia US Inc. | 1 | $22 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Pfizer | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $18 |
How this compares
$18,969 in reported general payments places this provider in the 80th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in South Boston
- Terrance TruittSouth Boston$108K
- Steven NathanFalls Church$2.5M
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Rabih HalabiFalls Church$604K
- Patricia SimeRichmond$572K
- Apostolos PerelasRichmond$567K
- Hannah MannemCharlottesville$326K
- Ray ShepherdRichmond$303K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.